1,167 Views
Adult ID
Investigative ID
Pediatric ID
Trainee
Transplant ID
Catherine Bollard, MD, FRACP, FRCPA
Bosworth Chair for Cancer Biology
Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine
Director,, Center for Cancer and Immunology Research
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Children's National Hospital and The George Washington University, Maryland
Disclosure: Cabaletta Bio : Board Member (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing); Catamaran Bio : Co-Founder / SAB / Stock Options (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Mana Therapeutics : Co-founder / SAB / Stock Options (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Neximmune : Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing); Repertoire Immune Medicines (formerly Torque Therapeutics) : Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing)
Paul Carpenter, MB. BS., BSc. (Med)
Full Member
Clinical Research Division
Fred Hutchinson Cancer Research Center; University of Washington
Seattle, Washington
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Brian Fisher, DO, MPH, MSCE
Associate Professor of Pediatrics and Epidemiology
Division of Infectious Diseases; Center for Pediatric Clinical Effectiveness
Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania
Disclosure: Astellas () : Advisor or Review Panel member; Merck () : Grant/Research Support; Pfizer () : Grant/Research Support
CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
No CPE Credits